KP Tissue Releases Second Quarter 2020 Financial Results
KPLP Q2 2020 Business and Financial Highlights • Revenue increased by $21.1 million or 5.8% to $386.8 million in Q2 2020 compared to $365.7 million in Q2 2019. Excluding the divested Mexico business, Q2 2020 revenue increased by $46.5 million or 13.7%. • Adjusted EBITDA was $64.4 million in Q2 2020 compared to $31.5 million in Q2 2019, an increase of 104.6%. • TAD Sherbrooke site progressing on time and on budget despite the temporary shutdown in Q1 2020 due to the implementation of strict COVID-19 protocols. • Declared a quarterly dividend of $0.18 per share to be paid on October 15, 2020.